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Abstract. We have examined the role of two mesen- 
chymal ligands of epithelial tyrosine kinase receptors in 
mouse mammary gland morphogenesis. In organ cul- 
tures of mammary glands, hepatocyte growth factor 
(HGF, scatter factor) promoted branching of the ductal 
trees but inhibited the production of secretory proteins. 
Neuregulin (NRG, neu differentiation factor) stimu- 
lated lobulo-alveolar budding and the production of 
milk proteins. These functional effects are paralleled by 
the expression of the two factors in vivo: HGF is pro- 
duced in mesenchymal cells during ductal branching in 
the virgin animal; NRG is expressed in the mesen- 
chyme during lobulo-alveolar development at preg- 
nancy. The receptors of HGF and NRG (c-met, c-erbB3, 
and c-erbB4), which are expressed in the epithelial 
cells, are not regulated. In organ culture, branching 
morphogenesis and lobulo-alveolar differentiation of 
the mammary gland could be abolished by blocking ex- 
pression of endogenous HGF and NRG by the respec- 
tive antisense oligonucleotides; in antisense oligonucle- 
otide-treated glands, morphogenesis could again be 
induced by the addition of recombinant HGF and 
NRG. We thus show that two major postnatal rnorpho- 
genic periods of mammary gland development are de- 
pendent on sequential mesenchymal-epithelial  interac- 
tions mediated by HGF and NRG. 
ROWTH and morphogenesis of epithelia represent 
essential steps  in the development of many eu- 
karyotic organs. A series of developmental studies 
have demonstrated that growth and morphogenesis of epi- 
thelia are closely regulated by mesenchymal-epithelial in- 
teractions. These studies  include transplantation and or- 
gan culture experiments, which have been carried out with 
various systems such  as the salivary gland,  the lung, the 
kidney, or the breast (Grobstein, 1953; Spooner and Wes- 
sells,  1970; Sax6n,  1987; Sakakura, 1991). The signaling 
molecules involved in mesenchymal-epithelial interactions 
during development are still largely unknown. Recent evi- 
dence suggests, however, that epithelial tyrosine kinase re- 
ceptors and their mesenchymal ligands can take over these 
functions (see Birchmeier and Birchmeier, 1993; for a re- 
view). 
Several tyrosine kinase receptors with prevalent expres- 
sion on epithelial cells have recently been characterized. 
The corresponding ligands  are frequently synthesized by 
mesenchymal cells, i.e., could function in a paracrine man- 
ner (Stoker et al., 1987; Miki et al., 1991; Sonnenberg et 
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al., 1991, 1993; Peles et al., 1992; Weidner et al., 1993; Schu- 
chardt et al., 1994). Since certain tyrosine kinase receptors 
were first discovered because of their transforming poten- 
tial when mutated, they have commonly been associated 
with mediating mitogenic signals. However, it has recently 
become  evident that tyrosine kinase receptors  can also 
regulate differentiation, cell movement, or morphogene- 
sis, i.e., these receptors and their ligands may direct deci- 
sive events in epithelial development (see Birchmeier and 
Birchmeier, 1993). For instance, hepatocyte growth factor 
(HGF)  1  has been shown to induce branching morphogene- 
sis  of kidney epithelial cells in vitro  (Montesano et al., 
1991). Cell biological and developmental studies have in- 
dicated that  HGF is  synthesized by mesenchymal (and 
neuronal) cells whereas its receptor, the tyrosine kinase 
c-met, is located in cells that potentially interact with mes- 
enchymal cells, e.g., epithelial cells  (Stoker et al.,  1987; 
Sonnenberg et al., 1993). Similarly, neuregulin (NRG) has 
been reported to affect growth and differentiation of epi- 
thelial (carcinoma) cells and is expressed in embryonic mes- 
enchyme and neuronal cells (Peles et al., 1992; Meyer and 
Birchmeier, 1994). Thus, HGF or NRG and the correspond- 
ing receptors represent ligand-receptor pairs that could me- 
1.  Abbreviations  used  in  this  paper:  ECM,  extracellular  matrix;  HGF, 
hepatocyte growth factor; NRG, neuregulin; WAP, whey acidic protein. 
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The importance of tyrosine kinase receptors in mesen- 
chymal-epithelial interactions during development of kid- 
ney, lung, and liver has recently been supported by genetic 
experiments. A targeted mutation was introduced into the 
murine c-ret gene, which is expressed during embryogene- 
sis at the tips of the branching ureter buds in the kidney. 
Animals carrying two mutant alleles show severe hypopla- 
sia or aplasia of the kidneys (Schuchardt et al., 1994). The 
ligand for c-ret is as yet unknown, but was suggested to de- 
rive from the mesenchyme. A  dominant-negative kerati- 
nocyte growth factor receptor under the control of a lung 
surfactant promoter was used to target expression to the 
embryonal lung buds  in  transgenic mice. Newborn mice 
that carry this transgene show severe defects in lung devel- 
opment, i.e., branching morphogenesis and differentiation 
of the lung epithelium is completely abolished (Peters et 
al., 1994).  Furthermore, a targeted mutation of the HGF 
gene in mice led to embryonal lethality caused by severe 
liver and placenta defects (Schmidt et al., 1995; Uehara et 
al.,  1995).  The development of both these organs is regu- 
lated by mesenchymal-epithelial interactions. 
To study molecular aspects  of mesenchymal-epitheliaI 
interactions, we used the mammary gland of female mice 
as an experimental system. The mammary gland is one of 
the few mammalian organs that undergoes major morpho- 
logical and functional changes after birth (for reviews see 
Daniel and Silberstein, 1987; Sakakura, 1991).  At birth, a 
primitive  epithelial  duct  with  few  side-branches  exists, 
which is embedded in the mesenchymal fat pad. During 
puberty, rapid  elongation  and branching of this primary 
epithelium proceeds until the ductal tree reaches the bor- 
der of the fat pad at 12 wk. At pregnancy, a second mor- 
phogenic phase begins with the budding of multiple alveoli 
from the ducts, which are assembled into lobules. These 
lobulo-alveolar structures are the functional units of milk 
production at lactation. After weaning, the glands undergo 
massive remodeling, which results in the regression of the 
lobulo-alveolar structures and the return to the stage  of 
the ductal tree. Branching morphogenesis and lobulo-alve- 
olar differentiation of the mammary gland are regulated 
by a complex interplay of systemic hormonal signals and 
local factors (for reviews see Daniel and Silberstein, 1987; 
Imagawa et al.,  1990).  In these processes, mesenchymal- 
epithelial  as well as  epithelial-mesenchymal interactions 
between the cells of the fat pad and of the ducts and alve- 
oli  play  a  role  (DeOme  et  al.,  1958;  for  review  see 
Sakakura,  1991).  Three modes of signal transduction be- 
tween mesenchyme and epithelium have been suggested: 
(a) interactions mediated by direct cell-cell contact; (b) in- 
teractions mediated  by the  extracellular matrix;  and  (c) 
diffusion of soluble factors (Levine and Stockdale, 1985; 
Sakakura, 1991; Howlett and Bissell, 1993). The identity of 
soluble factors involved in mesenchymaI-epithelial inter- 
actions during mammary gland development were previ- 
ously not known. 
We  have  here  identified  two  mesenchymal  factors, 
hepatocyte growth factor and neuregulin, that play impor- 
tant roles in the development of the mammary epithelium. 
HGF, which is identical to scatter factor, is the prototype 
of an emerging family of motility and growth factors that 
resemble in their domain structure and mechanism of acti- 
vation the blood proteinase plasminogen (Miyazawa et al., 
1989; Nakamura et al.,  1989; Weidner et al.,  1991; Hart- 
mann et al.,  1992).  The pleiotropic responses of HGF on 
cells are mediated by the receptor tyrosine kinase c-met 
(Bottaro et al.,  1991; Naldini et al.,  1991; Weidner et al., 
1993).  During  mouse  embryogenesis,  various  epithelia 
that form branching tubular structures, i.e., the lung, pan- 
creas, or salivary gland, express c-met, while the surround- 
ing mesenchyme produces HGF (Sonnenberg et al., 1993). 
Neuregulin, also called neu differentiation factor, heregu- 
lin, ARIA, glial growth factor, is a novel factor that has 
several functions on diverse cell types in culture: (a) induc- 
tion of growth and differentiation of mammary carcinoma 
cells; (b) induction of growth of glial cells and glial cell fate 
from neuronal precursor cells; and (c) induction of termi- 
nal differentiation of myotubes (Holmes et al., 1992; Peles 
et al., 1992; Falls et al., 1993; Marchionni et al., 1993; Shah 
et al.,  1994).  Various transcript isoforms (c~-, 13-, and iso- 
forms  containing  a  kringle-like  domain)  are  all  derived 
from one NRG gene by alternative splicing and probably, 
the use of two promoters (Falls et al., 1993; Marchionni et 
al.,  1993; Peles and Yarden,  1993; Wen et al.,  1994).  An 
epidermal growth factor (EGF)-like motif was  found to 
act as the essential functional domain in all NRG isoforms. 
Recently, it was shown that the interaction of NRG with 
the target cells is mediated by c-erb B4, which binds NRG 
directly and with high affinity (Plowman et al., 1993). Fur- 
thermore, c-erb B3 can act, alone or in combination with 
c-erbB2/neu or c-erb B4, as a  further receptor for NRG 
(Sliwkowski  et  al.,  1994;  Carraway  and  Cantley,  1994). 
NRG is expressed in various neuronal and mesenchymal 
tissues during mouse embryogenesis (Orr Urtreger et al., 
1993;  Meyer and  Birchmeier,  1994),  while  c-erbB3  and 
c-erbB4 are  frequently found in  cells  that  interact  with 
neuronal or mesenchymal cells such as glia, muscle, or epi- 
thelial cells (Kraus et al., 1989; Press et al., 1990; Prigent et 
al., 1992; Plowman et al., 1993). 
Materials and Methods 
Mammary Gland Organ Culture 
Whole mammary glands of hormonally primed mice were cultured in se- 
rum-free medium according to Banerjee et al. (1976):  4-wk-otd BALB/c 
mice were injected subcutaneously for nine consecutive days with 1 mg 
progesterone and 1 ~g estradiol (Sigma Chemical Co., St. Louis, MO) dis- 
solved in gummi arabicum/0.9% NaCl. The second pair of thoracic glands 
was excised and cultivated for 5 d on cyclopore membranes (Falcon Plas- 
tics, Cockeysville, MD) in 2 ml medium 199 with Hanks' salts (GIBCO 
BRL,  Gaithersburg, MD),  gentamycin (40  ixg/ml),  aldosterone,  bovine 
prolactin, insulin (each at 5 ixg/ml; Sigma), and hydrocortisone (1 ixglml; 
Merck, Darmstadt, Germany) (referred to as "APIH standard medium"). 
For experiments with NRG, prolactin concentration was reduced to 3 txg/ 
ml (modified  APIH  medium). Medium was changed every 2  d.  Three 
pairs of contralateral  glands were  routinely examined, one member of 
each pair was the test sample, the other the control. Formalin-fixed whole 
glands were stained with hematoxylin as described (Rivera, 1971). Stained 
glands were also embedded in paraffin, cut at 5 txm, and stained with he- 
matoxylin/eosin. For the analysis of milk production, 500 alveolar struc- 
tures on paraffine sections were examined in each experimental group for 
the presence of luminal secretory products and intraepithelial fat droplets 
(counted positive when >50% of epithelial cells contained droplets). 
The 17 mer phosphorothioate oligonucleotides used in the organ cul- 
ture were synthesized and purified by high-performance liquid chroma- 
tography (BioTez Berlin-Buch GmbH). Sequences were taken from the 
mouse HGF and NRG cDNAs, respectively, beginning with the transla- 
tion start (Sonnenberg et al., 1993; Meyer and Birchmeier, 1994): HGF an- 
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ACCAA-3';  NRG  antisense, 5'-TCTTTGCGCTCAGACAT-3', sense, 
5'-ATGTCTGAGCGCAAAGA-3'. The oligonucleotides were added to 
the medium at day 1 of the culture period and supplied with each medium 
change. 
Recombinant HGF and NRG 
Recombinant HGF was produced in Sf9 insect cells by means of the bacu- 
lovirus expression system as described (Weidner et al., 1993).  In selected 
experiments, we also used the a[3-heterodimeric form of HGF cleaved by 
urokinase-Sepharose (Higgins and Vehar, 1987; Naldini et al., 1992). The 
EGF-like  domain of the 13-isoform  of NRG was prepared  as described 
(Holmes et al. 1992;  Meyer and Birchmeier, 1993).  Alternatively, a  132a- 
subform of NRG was produced by the baculovirus expression system. The 
coding sequence (amino acids 20-239,  Wen et  al.,  1994)  was  fused in 
frame to the signal sequence of expression vector pAcGP67  (Dianova, 
Hamburg, Germany). NRGI32a was purified on heparin-Sepharose using a 
NaC1 gradient. 
Expression Analyses 
The second pairs of thoracic mammary glands from virgin, primiparous 
pregnant, lactating, or involuting BALB/c mice were prepared and snap 
frozen in liquid nitrogen. Total RNA was isolated according to Chom- 
czynski and Sacchi (1987). RNase protection was performed as described 
by Birchmeier et al. (1987). Probes were synthesized as run-off transcripts 
from the corresponding cDNAs in the pBluescript vector with T7 RNA 
polymerase using [a32p]UTP (specific activity of 3,000 Ci/mmol; NEN Du- 
Pont). The probes were (a) mHGF1, a 449-nt transcript containing 126 nt 
of the murine HGF cDNA in antisense orientation (positions 467-593); 
(b) mMetl, a  471  nt transcript containing 137  nts of the murine c-met 
cDNA in antisense orientation (positions 3867--4004)  and 334 nts of the 
plasmid derived sequence (Sonnenberg et  al., 1993);  (c) pNN,  a  390-nt 
transcript composed of 290 nts of the murine NRG cDNA in antisense ori- 
entation (positions 391~581 of the cDNA sequence) and additional 100 nts 
from the plasmid-derived sequence; (d) pNa, a 346-nt transcript contain- 
ing 259 nts of the murine NRG cDNA in antisense orientation (positions 
899-1158 in the rat cDNA sequence) and additional 87 nts from the plas- 
mid sequence (Meyer and Birchmeier, 1994);  and (e) p-erb B4, a 223-nt 
transcript containing 141 nts of the murine c-erb B4 cDNA in antisense 
orientation (corresponding to positions 2486-2627 in the human sequence, 
Plowman et al., 1993) and additional 82 nts of plasmid sequence. A 304-nt 
antisense transcript derived from the murine 13-actin cDNA containing 
250 nts of coding sequence, was used as a control. For detection of HGF 
and c-met mRNA fragments, 40 Ixg of total RNA were hybridized to the 
corresponding 32p-labeled transcripts (50,000 cpm of each probe). To ana- 
lyze NRG and c-erbB-4 mRNA, 35 gg and 100 Ixg of total RNA were hy- 
bridized, respectively. 
For in situ hybridization (Sonnenberg et al., 1991), cryostat sections of 
the  second thoracic mouse mammary glands at various developmental 
stages were  used. Antisense and  sense RNA  probes  were  synthesized 
from the cDNA fragments in the pBluescript vector with either T7 or T3 
RNA polymerase and 35S-labeled  UTP  and  CTP  (specific activities of 
>1,000 Ci/mmol). l0  s cpm of the labeled probes were used for hybridiza- 
tion. Probes  were  as  follows:  mHGF2,  obtained  from  a  murine  HGF 
cDNA (positions 1104-2634); mMet2, obtained from murine c-met cDNA 
(positions 2298-3974); pN1, obtained from murine NRG cDNA (corre- 
sponding to positions 391-1458); murine p-erbB4, corresponds to positions 
834-2628.  For  Northern blot  analysis, total  RNA  (15  ttg)  was electro- 
phoresed in 1% agarose-formaldehyde gels, transferred to Hybond C-extra 
membranes (Amersham International, Amersham, UK), and hybridized 
to 32p-labeled cDNA probes followed by autoradiography (Sambrook et 
al., 1989).  Murine cDNA probes for [3-casein  (Binas et al., 1992),  whey 
acidic protein (WAP, a kind gift of Dr. Nancy Hynes, Friedrich-Miescher- 
Institut, Basel) and [3-actin were labeled by random priming (109 cpm/~Lg; 
Feinberg and Vogelstein, 1984).  Hybridization signals were analyzed with 
a Phosphorlmager. 
Results 
Effects of HGF and NRG in Mammary Gland 
Organ Culture 
Mammary  gland  organ  cultures  were  established  from 
hormonally primed mice at the age of four weeks (see Ma- 
terials and Methods).  At this stage, a sparsely developed 
epithelial  tree with few end buds occupies ~40%  of the 
mammary fat pad. Under optimal conditions for organ cul- 
ture,  ductal  branching  and  alveolar morphogenesis  take 
place within the next week leading to a glandular tree with 
lobulo-alveolar structures  and the synthesis of milk con- 
stituents (Fig. 1, a, c, and e). This organ culture system thus 
allows testing  the  effects of exogenous  and  endogenous 
modulators on the various developmental processes, both 
in  terms  of kinetics  and  end  points.  Since  contralateral 
pairs of glands exhibit virtually identical patterns of epi- 
thelial morphogenesis, the effect of factors on one mem- 
ber of the paired glands can be easily compared to the un- 
treated control. 
In organ culture, treatment of glands in standard APIH 
(serum-free)  medium with  recombinant HGF (at 20  ng/ 
ml) for five days resulted in the appearance of unusually 
strongly branched glandular trees (compare Fig. 1, b and d 
with a and c). In the control, the primary ducts that origi- 
nate from the nipple have few small side branches (Fig. 1, 
a  and c, arrows). In the  presence  of HGF, branching  is 
strongly intensified resulting in numerous main ducts that 
elongate toward the border of the fat pad (Fig. 1, b and d, 
arrows). Morphometric  analysis  revealed  an  average  of 
two  main side  branches  (range  1-3)  in  the  absence  and 
side  side  branches  (range  3-8)  in  the  presence  of HGF 
(seven  pairs  of glands  were  examined).  Concomitantly, 
HGF inhibited the secretory activity of the epithelial cells 
(Fig. 1, e and f): 82 ___ 3% of the alveoli displayed secretory 
activity in  the  absence  and 26  ±  2%  in  the presence of 
HGF (four pairs of glands were counted). Concentrations 
of HGF at 20 ng/ml were most effective for the stimulation 
of ductal branching; lower concentrations were less effec- 
tive,  100  ng/ml  slightly  inhibited  development  of  the 
glands. 
In contrast,  the  addition  of recombinant NRG to  the 
culture medium for five days stimulated the production of 
lobulo-alveolar structures. This was particularly obvious at 
reduced  prolactin  concentration  (i.e.,  in  modified APIH 
medium),  i.e.,  at  conditions  where  differentiation  is  de- 
layed. In the control glands, only single alveoli developed 
(Fig. 2, a and c). In the presence of NRG (3 nM), the num- 
ber of alveoli was markedly increased and they were clus- 
tered into lobules (Fig. 2, b and d; arrows). Morphometric 
measurement (see Fig.  2  legend) revealed an average of 
three lobules per analyzed field (range 0-6) in the absence 
and 17 lobules (range 10-30) in the presence of NRG (five 
pairs  of glands were  examined). The concentration  of 3 
nM was found to be optimal for both the soluble 13-form 
and the  EGF-like domain of NRG. Histological analysis 
corroborated the more progressed lobular development in 
the presence of NRG and showed increased luminal pro- 
tein secretion  and intracellular fat droplet accumulation: 
21  +-- 9% of the alveoli displayed secretory activity in the 
absence and 97 -+ 2% is the presence of NRG. Fat droplet- 
positive alveoli increased  from 20  -+  8%  to 99%  (seven 
pairs of glands were examined). 
We also analyzed in organ culture  the effects of HGF 
and NRG on the expression of milk proteins [3-casein  and 
WAP. HGF added to single members of paired glands in 
standard  APIH medium markedly reduced  13-casein  and 
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mammary  gland  morphol- 
ogy in organ culture.  Whole 
mouse  mammary  glands 
were  cultured  for  5  d  in 
APIH standard  medium, (a, 
c, and e) in the absence or (b, 
d,  and f) in  the presence of 
20 ng/ml recombinant HGF. 
(a and b) Whole mount stain- 
ing with hematoxylin; pl and 
p2 indicate pairs of contralat- 
eral glands. (c and d) Higher 
magnification of the areas in- 
dicated  in a and b by arrow- 
heads. (e and f) Histology of 
sections  of  cultured  glands 
stained  with  hematoxylin/ 
eosin.  Arrows indicate  filled 
(e)  or empty alveoli  (f), re- 
spectively. Bars: (e and f) 100 
Ixm. Morphometry of branch- 
ing (see text) was performed 
in  areas  of  newly  formed 
structures (see Fig. 1, c and d). 
abolished WAP expression (Fig. 3 A, compare lanes 2 and 
4  with 3  and 5).  In contrast, NRG  (at reduced  prolactin 
concentration, i.e., modified APIH medium) induced  the 
expression of WAP and 13-casein (Fig. 3 B, compare lanes 
2 and 4 with 3 and 5). We also examined EGF for its effect 
in the organ culture system: EGF stimulated ductal prolif- 
eration but not branching. Furthermore, EGF inhibited al- 
veolar maturation and milk production (data not shown). 
Expression of  HGF and NRG During Mammary Gland 
Development In Vivo 
To examine whether HGF and NRG could possibly have 
the  suggested functions  in  vivo, we  examined  by RNase 
protection  analysis  the  temporal  and  spatial  expression 
pattern  of the  two  factors  during  the  various  stages  of 
mammary gland  development.  We  found  that  HGF ex- 
pression is strongly regulated during mammary gland de- 
velopment, reaching the highest level during ductal mor- 
phogenesis  in  the  virgin  animal  (Fig.  4,  A  and  B). 
Expression levels decrease during pregnancy and lactation 
and increase again during involution. Quantitative analysis 
showed that HGF expression at 12 wk is upregulated by 
approximately one order of magnitude  in comparison to 
the lactation stage. A  single fragment, 126 nucleotides  in 
length, was observed in the RNase protection analysis, in- 
dicating that the splice variant encoding HGF with addi- 
tional five amino acids in kringle 1 (Weidner et al., 1991) is 
expressed in the mammary gland. In contrast, mRNA lev- 
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mammary  gland  morphol- 
ogy in  organ  culture.  Mam- 
mary  glands  were  cultured 
for  5  d  in  modified  APIH 
medium,  (a,  c, and e) in the 
absence or (b,  d, and f)  the 
presence  of  3  nM  recombi- 
nant NRG. To decrease alve- 
olar  development,  the  con- 
centration of prolactin in the 
medium was reduced to 3 ~g/ 
ml  (modified  APIH  me- 
dium).  (a  and  b)  Whole 
mount staining;  pl and p2 in- 
dicate  pairs  of contralateral 
glands.  (c  and  d)  Higher 
magnification of the areas in- 
dicated in a and b by arrow- 
heads  demonstrates  the  in- 
creased density and thickness 
of  lobular  alveoli  in  the 
glands treated with NRG. (e 
and f)  Histological  analysis. 
Arrows  indicate  empty  (e) 
and filled  alveoli  (f), respec- 
tively.  Morphometry of lob- 
ule formation (see text)  was 
performed in areas that were 
newly  formed  during  organ 
culture (see field  of Fig. 2, c 
and d). Bar, 100 p~m. 
els for the HGF receptor c-met (and for actin as a control) 
did not change significantly during mammary gland devel- 
opment. 
NRG showed a  completely different but again strongly 
regulated  expression  pattern:  the  highest  level  of  tran- 
script  is  observed  during  the  process  of lobulo-alveolar 
morphogenesis at pregnancy (Fig. 4, A  and  C). No NRG 
mRNA  was measured  during  the  virginal period  (except 
for a weak signal in the adult animal at 12 wk), and expres- 
sion again sharply decreased during lactation and was ab- 
sent during involution. NRG expression at pregnancy was 
two  orders  of magnitude  higher  than  in  the  adult  stage. 
The presence of a protected band at 259 nt in length using 
probe pNct indicates that the ere-subtype of NRG (see Pe- 
les and Yarden,  1993; Meyer and Birchmeier,  1993) is ex- 
pressed  during  pregnancy;  no  protected  fragment  of  13 
variants  (at  120 nt) was observed. RNase protection with 
probe pNN yielded no 240-nt fragment (as in brain, Fig. 4 
D) and therefore, subforms containing the kringle-like do- 
main are  also not expressed  in the  mammary gland.  The 
expression of the high affinity receptor of NRG was also 
examined; c-erbB4 is not expressed in the glands of prepu- 
bertal mice but is seen at approximately the same level in 
the virgin animals and in all further stages of development 
(Fig. 4 C). 
HGF and NRG expression during mammary gland de- 
velopment was also examined by in situ hybridization: in 
the  adult  gland,  HGF  transcripts  are  detected  in  a  thin 
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teins in organ culture. The expression of I3-casein and whey acidic 
protein (WAP) in two pairs of contralateral  glands (one member 
of the pairs was treated, the other non-treated) was analyzed by 
Northern blotting. (A) Effect of 20 ng/ml HGF after 5 d of organ 
culture  in standard  APIH medium: (lanes 2 and 4) RNA from 
control glands; (lanes 3 and 5) RNA from treated contralateral 
glands. (B) Effect of 3 nM NRG after 5 d of organ culture in 
modified APIH medium (see legend to Fig. 2): (lanes 2 and 4) 
RNA from control glands; (lanes 3 and 5) RNA from treated con- 
tralateral  glands. (lane 1 in A and B) RNA from noncultivated 
glands. 
layer of mesenchymal cells adjacent to the ductal epithe- 
lium (Fig. 5 A, a). In contrast, the transcripts for the c-met 
receptor are localized within the basal epithelial cell layer 
of the ductal epithelium (Fig. 5 A, b). At pregnancy, NRG 
transcripts  are  widely detected  in  the  connective tissue 
around both ductal and alveolar structures (Fig. 5 B, a and 
b). In contrast, the receptors c-erbB4 and c-erbB3 are ex- 
pressed in the epithelium (shown for c-erbB4 in Fig. 5 B, c). 
Effects of Treatment of Mammary Gland Organ 
Cultures with Antisense Oligonucleotides 
Evidence for an  obligatory function of HGF and  NRG 
during  branching  and  lobulo-alveolar morphogenesis  of 
the mammary gland, respectively, is provided by interfer- 
ence  with  antisense  phosphorothioate  oligonucleotides. 
We first established the pattern of expression of both fac- 
tors during our standard organ culture: HGF mRNA is ex- 
pressed at the start of culture and slowly decreases, while 
NRG mRNA  expression is initially absent but increases 
from day 3 on (data not shown, see also Fig. 6 A). Treat- 
ment  of organ  cultures  with  antisense  HGF oligonucle- 
otide (see Materials and Methods) abolished the expres- 
sion of HGF mRNA, whereas sense oligonucleotide had 
no effect (Fig. 6 A, compare lanes 3 and 4). Treatment of 
glands with antisense NRG strongly reduced expression of 
NRG mRNA  (Fig. 6 A, compare lanes  7 and 8). Micro- 
scopic inspection showed that antisense HGF oligonucle- 
otide blocked ductal branching of the glands (Fig. 6 B, b 
and d, arrows and arrowheads), while the sense oligonu- 
cleotide had no effect (Fig. 6 B, a and c). Antisense NRG 
oligonucleotide quenched lobulo-alveolar development to 
a stage where mainly primary ducts are present (Fig. 6 B, f 
and h, arrowheads). Again, the corresponding sense oligo- 
nucleotide had no effect on lobulo-alveolar development 
(Fig.  6  B, e  and g).  NRG  antisense  oligonucleotide also 
markedly  reduced  milk  protein  expression  (data  not 
shown). Titration of biological activity of antisense oligo- 
nucleotides showed maximum effects at 10 (for HGF) and 
3 ~M (for NRG). 
We  also  demonstrate  that  the  effects of treatment  of 
mammary  glands  with  antisense  oligonucleotides  were 
compensated by addition  of appropriate  exogenous fac- 
tors. Thus, HGF fully restores ductal branching in glands 
treated  with  HGF  antisense  oligonucleotides  (Fig.  7  A, 
compare a  and b). In the histological analysis, numerous 
developing side branches were seen after HGF treatment 
(arrows in Fig. 7 A, d, compare with the control in c). Sim- 
ilarly, exogenous NRG restores lobulo-alveolar develop- 
ment of the glands treated with NRG antisense oligonu- 
cleotide (Fig.  7  B, compare a  and  b).  As  shown by the 
histological analysis, antisense NRG oligonucleotide fully 
quenched  alveolar  budding;  only intraductal  precursors 
were present (Fig. 7 B, c, arrows). Addition of exogenous 
NRG  overcame the  effect of antisense  oligonucleotide, 
i.e., fully supported budding and maturation (Fig. 7 B, d). 
Discussion 
We  demonstrate  here  that  two  mesenchymal  factors, 
hepatocyte growth factor and neuregulin, control morpho- 
genesis  and  differentiation  of  epithelia  during  mouse 
mammary  gland  development.  In  organ  culture,  exoge- 
nously added HGF induces intensive branching of mam- 
mary ducts, whereas exogenous NRG promotes the for- 
mation  of  lobular  alveoli  that  is  followed  by  terminal 
differentiation. The respective antisense oligonucleotides 
abolish morphogenesis and differentiation of the glands, 
apparently by interfering with expression of endogenous 
HGF and NRG.  Furthermore, the in vivo expression of 
the two factors closely parallels their functional role, i.e., 
HGF is  produced during the ductal  branching period in 
virgin mice, whereas NRG is strongly induced during lob- 
ulo-alveolar development at pregnancy. Thus, two essen- 
tial steps in mammary gland development can now be ex- 
plained  on  a  molecular  level:  the  specific  morphogens 
HGF  and  NRG  are  induced in  the  mesenchyme of the 
gland and then affect the nearby epithelium. Apparently, 
the expression of HGF and NRG is under tight hormonal 
control. We also show that the epithelial tyrosine kinase 
receptor c-met  and  the  corresponding c-erbB  receptors 
are  expressed  at  appropriate  times  during  the  develop- 
ment of the mammary gland and therefore likely represent 
critical components in  the response to the mesenchymal 
signals. 
It has previously been found that HGF is an inducer of 
branching  morphogenesis  of MDCK  (kidney)  epithelial 
cells in collagen gels (Montesano et al.,  1991). Similarly, 
HGF  promoted  the  formation  of  branching  duct-like 
structures of mammary gland and other epithelial cells in 
collagen gels (Soriano et al., 1995; V. Brinkmann and W. 
Birchmeier, manuscript submitted for publication).  Dur- 
ing mouse embryogenesis, the HGF receptor c-met is ex- 
pressed in many tubular epithelia, for example, in branch- 
ing epithelia of kidney, lung, salivary glands, and pancreas 
(Sonnenberg et al., 1993).  In contrast, HGF expression is 
found in mesenchyme surrounding these tubular epithelia. 
HGF expression is also detected in primary fibroblasts iso- 
lated from human breasts, and c-met is located on ductal 
epithelial cells (Tsarfaty et al., 1992; Seslar et al., 1993). In 
the present study, we show that HGF is essential for induc- 
tion  of  branching  of mammary  ducts  in  organ  culture 
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of HGF and NRG during mammary 
gland development.  (A)  Quantita- 
tive patterns of expression levels for 
HGF  (11) and  the  a2-subtype  of 
NRG (A) were evaluated from the 
results of Fig. 4, B and  C by phos- 
phoimage  analysis.  Radioactive 
counts  are  expressed  as  PSL. (B) 
RNase protection  analysis of HGF 
and c-met expression during the de- 
velopment  of  mouse  mammary 
glands. Total RNA of whole mam- 
mary  glands from  postnatal  (2,  6, 
and 12 wk old), from pregnant (at 7 
and  15 d), and  from lactating  and 
involuting  mice was  subjected  to 
RNase protection with a HGF tran- 
script probe (mHGF1), with a c-met 
probe (mMetl),  or an actin control 
probe (see Materials and Methods). 
m,  Markers  (MspI-digested  pBR 
322); t-RNA, control digest; input, 
nondigested  probe.  (C  and  D) 
RNase protection  analysis of NRG 
and  c-erb  B4  expression  in  the 
mouse mammary gland. Total RNA 
from mammary glands of the differ- 
ent stages was subjected to RNase 
protection  analysis using probe 
pNc~ for NRG and probe  c-erbB4. 
In D probe pNN for NRG was used 
(see Meyer and Birchmeier, 1994). 
rn, Markers; tRNA, control  digest; 
input, nondigested probe. 
(Figs.  1 d  and 7 A).  Specific antisense  HGF oligonucle- 
otides fully prevented endogenous branching that could be 
overcome by the  addition  of exogenous factor. Further- 
more, HGF is expressed during virginhood exclusively in a 
thin layer of mesenchymal cells  located around the ducts, 
whereas the c-met receptor is located in the basal layer of 
epithelial cells. This indicates that HGF functions in para- 
crine manner and provides a molecular basis for the local 
interactions between mesenchymal and epithelial cells. In- 
terestingly, HGF in organ culture inhibited lobulo-alveo- 
lar  development  and  milk  production,  indicating  that 
branching morphogenesis must precede functional differ- 
entiation. This is in line with the fact that ductal growth in 
vivo occurs mainly during virginhood whereas functional 
differentiation is a subsequent event during pregnancy. 
It  has  previously  been  shown  that  NRG  can  induce 
growth and differentiation of epithelial cells  in vitro, e.g., 
breast  cancer cell  lines  respond  with  the  production  of 
milk proteins (Wen et al., 1992; Bacus et al., 1993; Culous- 
cou et al.,  1993).  NRG stimulated the expression of a 22- 
kD milk protein but inhibited DIP-induced expression of 
[3-casein in HCll mouse mammary epithelial cells  (Marte 
et al.,  1995).  During embryogenesis of the mouse, a high 
concentration of NRG transcripts in the immediate vicin- 
ity of epithelia of many developing organs was observed 
(Meyer and Birchmeier, 1994). We demonstrate here that 
NRG  plays  an  essential  role  during  differentiation  of 
mammary epithelia  in  vivo.  In  organ  culture,  NRG  in- 
duces  the  production of alveoli  that  are  assembled  into 
lobules (Figs.  2 d and 7 B) and promotes the expression of 
milk proteins 13-casein and WAP. Furthermore, NRG ex- 
pression in the stroma of the mammary gland is strongly 
Yang et al. HGF and NRG in Mammary Gland Development  221 Figure 5.  Cellular localization of HGF, c-met, NRG, and c-erbB4 expression in the mammary gland by in situ hybridization  and bright 
field illumination.  Sections of mammary glands of 12 wk adult  (A, a and b) and 15 d pregnant mice (B, a-c) were hybridized  with the 
HGF antisense probe mHGF2 (A, a), with the c-met antisense probe mMet2 (A, b), with the NRG antisense probe pN1 (B, a and b), or 
with the c-erbB4 antisense probe (B, c). Bars: (A, a and b) 20 Ixm;  (B, a) 40 Ixm;  (B, b and c) 20 txm. 
induced  at pregnancy, i.e., at times when lobulo-alveolar 
structures develop; specific antisense oligonucleotides in- 
hibited lobule formation and production of milk proteins. 
We also show that an a-isoform of NRG, i.e., a mesenchy- 
mal form, is  expressed during  mammary gland  morpho- 
genesis. Thus, NRG is a further key player in the mesen- 
chymal-epithelial  interactions  of  the  mammary  gland 
which, in comparison to HGF, produces a qualitatively dif- 
ferent response. Signal transduction  by c-met and c-erbB 
receptors have recently been examined: HGF acts through 
a single receptor that activates characteristic downstream 
substrates  (Hartmann  et  al.,  1994;  Ponzetto  et  al.,  1994; 
Weidner et al., 1995).  In contrast, NRG binding and signal 
transduction appears to involve complex hetero-oligomer- 
ization between  three  c-erbB receptors (Plowman et  al., 
1993; Sliwkowski et al., 1994)  and therefore, multiple sig- 
nal transduction pathways are involved (Ben  Levy et al., 
1994;  Carraway  and  Cantley,  1994;  Prigent  and  Gullick, 
1994).  Further understanding  of the complex interplay of 
downstream targets of c-met and the c-erbBs is required to 
explain the different signaling capacities of the two recep- 
tor systems in mammary gland development. 
Morphogenesis and regression of the mammary gland is 
accompanied by extensive extracellular matrix (ECM) re- 
modeling  that  is mediated  by ECM-degrading  proteases 
(Talhouk et al., 1991; Sympson et al., 1994).  This is in line 
The Journal of Cell Biology, Volume 131, 1995  222 Figure 6.  Effect of HGF and NRG antisense oligonucleotides  in mammary gland organ culture. Mammary glands were cultured in stan- 
dard APIH medium for 4 d (for HGF interference) and 6 d (for NRG interference) in the presence of the corresponding sense or anti- 
sense oligonucleotide phosphorothioates: (A) RNase protection analysis of HGF (lanes 2--4) and NRG expression (lanes 6--8). (lanes 1 
and 5) Input band; (lanes 2 and 6) untreated gland; (lanes 3 and 7) sense oligonucleotide; (lanes 4 and 8) antisense oligonucleotide (10 
and 3 IxM for interference with HGF and NRG transcript formation, respectively), m, Marker. (B) Morphological evaluation of the ef- 
fect of treatment with antisense oligonucleotides: (a and c) 10 ~xM HGF sense oligonucleotide; (b and d) 10 ~zM HGF antisense oligonu- 
cleotide; (e and g) 3 txM NRG sense oligonucleotide; (land h) 3 IxM NRG antisense oligonucleotide, c, d, g, and h show higher magnifi- 
cations of the indicated areas in a, b, e, and f(see arrows). 
Yang et al. HGF and NRG in Mammary Gland Development  223 Figure Z  Restoration of branching morphogenesis and differentiation  in antisense  oligonacleotide-treated organ cultures  by the addi- 
tion of exogenous HGF and NRG. (A) Paired glands were cultured for 4 d in the presence of 10 p~M HGF antisense  oligonucleotide  in 
the absence (a and c) and presence of 20 ng/ml exogenous HGF (b and d). Arrows in (d) indicate developing side branches.  (B) Paired 
glands were cultured for 6 d in the presence of 3 ixM NRG antisense oligonucleotide  in the absence (a and c) and presence of 3 nM NRG 
(b and d). Arrows in c indicate intraductal  alveolar precursors. 
with the fact that HGF induces synthesis and secretion of 
proteases in epithelial cells (Pepper et al., 1992).  Protease 
activities are also increased during involution (Talhouk et 
al., 1992),  i.e., at times when HGF is highly expressed. In 
cell culture of mammary epithelial cells, NRG induces the 
expression of cell adhesion molecules such as ICAM-I and 
E-cadherin (Bacus et al., 1993; Staebler et al., 1994), which 
might be important for alveolar maturation and tissue-spe- 
cific gene regulation. Various growth factors such as EGF, 
TGFa, and TGFI31 are suppressors of HGF expression of 
fibroblasts in cell culture (Gohda et al., 1992; Seslar et al., 
1993). These factors are produced in the epithelium of the 
mammary gland during postnatal development and influ- 
ence ductal and alveolar development mainly in an auto- 
crine  manner  (Vonderhaar,  1987;  Coleman  et  al.,  1988; 
Snedeker et al.,  1991;  Silberstein et al.,  1992;  Jhappan et 
al.,  1993;  Pierce  et  al.,  1993;  Spitzer et  al.,  1995).  Other 
growth  and  differentiation  factors  are  also  expressed  in 
the mammary gland, i.e., several members of the FGF and 
wnt  families  (Gavin  and  McMahon,  1992;  Coleman- 
Krnacik and Rosen, 1994;  Ulich et al., 1994).  The regula- 
tion of HGF and NRG synthesis in the mesenchyme dur- 
ing  postnatal  mammary gland  development  is  obviously 
under  control  of systemic hormones.  Mammary stromal 
cells  in  fact  respond  to  hormonal  signals  (Haslam  and 
Counterman,  1991),  and  glucocorticoids  downregulate 
HGF expression in  cell culture  (Gohda et  al.,  1992).  In- 
creasing levels of glucocorticoids in the circulation might 
thus  be  responsible  for  decreasing  HGF  levels  during 
pregnancy. In the mammary gland, reciprocal interactions 
of mesenchyme and epithelia are also apparent: our exper- 
iments show that mammary fat pads cleared of epithelia 
do  not  express HGF or NRG.  The  molecular nature  of 
these epithelial signals is not yet known. 
In conclusion, morphogenesis and differentiation of the 
mammary gland is regulated by a complex interplay of sys- 
temic hormones  and  local  factors:  mesenchymal cells of 
the  fat pad  appear  to  respond  to  hormonal  stimuli  and 
then produce short-range signals that control growth, mor- 
phogenesis, and differentiation of the epithelia.  Our data 
suggest that puberty hormones, directly or indirectly, con- 
trol the  synthesis of HGF in  the  local mesenchyrne, and 
demonstrate that this mesenchymal factor induces branch- 
ing  of epithelial  ducts.  At  a  later stage  of development, 
The Journal of Cell Biology, Volume 131, 1995  224 pregnancy  hormones  appear  to  control  the  synthesis  of 
NRG in the local mesenchyme, and we demonstrate that 
this mesenchymal factor induces lobulo-alveolar develop- 
ment and milk production of the mammary gland epithe- 
lium. Thus, the molecular nature of two sequentially ex- 
pressed  factors  has  been  elucidated,  that  control  the 
postnatal development of the mammary gland. Many fac- 
tors have been tested for functional effects on mammary 
gland epithelium. HGF and NRG are the only known fac- 
tor  that  can  induce  branching  and  lobulo-alveolar  mor- 
phogenesis in this system. Together with the high levels of 
HGF  and  NRG  during  puberty  and  pregnancy,  respec- 
tively,  and the  tight regulation of gene  expression  in the 
local mesenchyme, this provides strong evidence for a cru- 
cial  role  of  the  two  factors  in  morphogenesis  and  dif- 
ferentiation of the mammary gland. 
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